Björnsson E, Mueller T C, Kowalski A. "一种的合成方法" [P]. European Patent, EP 3464336 A1, 2023-04-17.
Kumar R, Davis P L, Lee S K. "Method for the Synthesis of (3-Methoxy-5-methylpyrazin-2-yl)methanol" [P]. US Patent, US 11274937 B2, 2015-08-17.
Davis P L, Roberts E F, Thompson G K. "A Process for Preparing High-Purity (3-Methoxy-5-methylpyrazin-2-yl)methanol" [P]. US Patent, US 11519987 B2, 2017-08-12.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2025, 1339, 3603-3625.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Environ. Sci. Technol., 2020, 1032, (12), 6085-6094.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of (3-Methoxy-5-methylpyrazin-2-yl)methanol Using HRMS and NMR". Biomed. Chromatogr., 2023, 1181, (2), 9418-9439.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Molecules, 2020, 1242, 1015-1028.